| Net clinical benefit of antithrombotic therapy in patients with atrial fibrillation and chronic kidney disease: a nationwide observational cohort study AN Bonde, GYH Lip, AL Kamper, PR Hansen, M Lamberts, K Hommel, ... Journal of the American College of Cardiology 64 (23), 2471-2482, 2014 | 347 | 2014 |
| Stroke and recurrent haemorrhage associated with antithrombotic treatment after gastrointestinal bleeding in patients with atrial fibrillation: nationwide cohort study L Staerk, GYH Lip, JB Olesen, EL Fosbøl, JL Pallisgaard, AN Bonde, ... Bmj 351, 2015 | 176 | 2015 |
| Ischaemic and haemorrhagic stroke associated with non-vitamin K antagonist oral anticoagulants and warfarin use in patients with atrial fibrillation: a nationwide cohort study L Staerk, EL Fosbøl, GYH Lip, M Lamberts, AN Bonde, C Torp-Pedersen, ... European heart journal 38 (12), 907-915, 2017 | 119 | 2017 |
| Standard and reduced doses of dabigatran, rivaroxaban and apixaban for stroke prevention in atrial fibrillation: a nationwide cohort study L Staerk, TA Gerds, GYH Lip, B Ozenne, AN Bonde, M Lamberts, ... Journal of internal medicine 283 (1), 45-55, 2018 | 113 | 2018 |
| Risk of myocardial infarction in anticoagulated patients with atrial fibrillation CJY Lee, TA Gerds, N Carlson, AN Bonde, GH Gislason, M Lamberts, ... Journal of the American College of Cardiology 72 (1), 17-26, 2018 | 73 | 2018 |
| Renal function and the risk of stroke and bleeding in patients with atrial fibrillation: an observational cohort study AN Bonde, GYH Lip, AL Kamper, EL Fosbøl, L Staerk, N Carlson, ... Stroke 47 (11), 2707-2713, 2016 | 71 | 2016 |
| Blood–brain barrier permeable β-blockers linked to lower risk of Alzheimer’s disease in hypertension EE Beaman, AN Bonde, SMU Larsen, B Ozenne, TJ Lohela, ... Brain 146 (3), 1141-1151, 2023 | 55 | 2023 |
| Combining oral anticoagulants with platelet inhibitors in patients with atrial fibrillation and coronary disease C Sindet-Pedersen, M Lamberts, L Staerk, A Nissen Bonde, JS Berger, ... Journal of the American College of Cardiology 72 (15), 1790-1800, 2018 | 50 | 2018 |
| Oral anticoagulation among atrial fibrillation patients with anaemia: an observational cohort study AN Bonde, P Blanche, L Staerk, TA Gerds, A Gundlund, G Gislason, ... European Heart Journal 40 (46), 3782-3790, 2019 | 47 | 2019 |
| Osteoporotic fractures in patients with atrial fibrillation treated with conventional versus direct anticoagulants C Binding, J Bjerring Olesen, B Abrahamsen, L Staerk, G Gislason, ... Journal of the American College of Cardiology 74 (17), 2150-2158, 2019 | 46 | 2019 |
| Resumption of oral anticoagulation following traumatic injury and risk of stroke and bleeding in patients with atrial fibrillation: a nationwide cohort study L Staerk, EL Fosbøl, M Lamberts, AN Bonde, K Gadsbøll, ... European Heart Journal 39 (19), 1698-1705a, 2018 | 39 | 2018 |
| Risk of gastrointestinal adverse effects of dabigatran compared with warfarin among patients with atrial fibrillation: a nationwide cohort study L Staerk, GH Gislason, GYH Lip, EL Fosbøl, ML Hansen, M Lamberts, ... EP Europace 17 (8), 1215-1222, 2015 | 38 | 2015 |
| Rivaroxaban versus apixaban for stroke prevention in atrial fibrillation: an instrumental variable analysis of a nationwide cohort AN Bonde, T Martinussen, CJY Lee, GYH Lip, L Staerk, CN Bang, ... Circulation: Cardiovascular Quality and Outcomes 13 (4), e006058, 2020 | 29 | 2020 |
| Prediabetes Defined by First Measured HbA1c Predicts Higher Cardiovascular Risk Compared With HbA1c in the Diabetes Range: A Cohort Study of Nationwide … SK Yahyavi, O Snorgaard, FK Knop, M Schou, C Lee, C Selmer, ... Diabetes Care 44 (12), 2767-2774, 2021 | 27 | 2021 |
| Initiation of anticoagulation in atrial fibrillation: which factors are associated with choice of anticoagulant? A Gundlund, L Staerk, EL Fosbøl, K Gadsbøll, C Sindet‐Pedersen, ... Journal of Internal Medicine 282 (2), 164-174, 2017 | 26 | 2017 |
| Outcomes among patients with atrial fibrillation and appropriate anticoagulation control AN Bonde, L Staerk, CJY Lee, NE Vinding, CN Bang, C Torp-Pedersen, ... Journal of the American College of Cardiology 72 (12), 1357-1365, 2018 | 25 | 2018 |
| Effect of reduced renal function on time in therapeutic range among anticoagulated atrial fibrillation patients AN Bonde, GYH Lip, AL Kamper, L Staerk, C Torp-Pedersen, ... Journal of the American College of Cardiology 69 (6), 752-753, 2017 | 25 | 2017 |
| Renal function, time in therapeutic range and outcomes in warfarin-treated atrial fibrillation patients: a retrospective analysis of nationwide registries AN Bonde, GYH Lip, AL Kamper, L Staerk, C Torp-Pedersen, G Gislason, ... Thrombosis and Haemostasis 117 (12), 2291-2299, 2017 | 23 | 2017 |
| Cardiovascular outcomes with GLP-1 receptor agonists vs. SGLT-2 inhibitors in patients with type 2 diabetes CH Nørgaard, L Starkopf, TA Gerds, P Vestergaard, AN Bonde, E Fosbøl, ... European Heart Journal-Cardiovascular Pharmacotherapy 8 (6), 549-556, 2022 | 22 | 2022 |
| Symptomatic venous thromboembolism after Achilles tendon rupture: a nationwide Danish cohort study of 28,546 patients with Achilles tendon rupture MH Pedersen, LR Wahlsten, H Grønborg, GH Gislason, MM Petersen, ... The American journal of sports medicine 47 (13), 3229-3237, 2019 | 22 | 2019 |